An Open-Label, Long-term Study of GFB-887 in Patients With Glomerular Kidney Diseases
Conditions: Kidney Diseases; Glomerulosclerosis; Focal Segmental Nephrosis; Lipoid Urologic Disease; Glomerulonephritis; Nephritis; Nephrosis Intervention: Drug: GFB-887 Sponsor: Goldfinch Bio, Inc. Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - July 6, 2021 Category: Research Source Type: clinical trials
Recovering Damaged Cells for Sequelae Caused by SARS-CoV-2
Conditions: Sequelae of; Infection; Post Infection Glomerulonephritis; Post-Infectious Peripheral Neuralgia; Post-Infectious Disorder (Disorder); Post-Infectious Arthritis; Post-Infectious Polyneuritis; Post-Infectious Parkinsonism; Post-Infectious Hypothyroidism; Post I nfectious Osteoarthritis; Anxiety Disorders; Depression; Depression, Anxiety; Depression, Bipolar; Insomnia; GERD; Gastro Esophageal Reflux; Hepatitis; Glomerulonephritis Interventions: Combination Product: FurWat; Combination Product: FurFat; Combination Product: PurAp...
Source: ClinicalTrials.gov - April 15, 2021 Category: Research Source Type: clinical trials
